narcaricin mite benzbromarone tablet 50mg per tablet 10tablets per blister per box

ertongshu benzbromarone tablet 50mg per tablet 10tablets per box

Description

Indication & Scope

Narcaricin mite®/ErTongShu® is a prescription uricosuric agent indicated for the treatment of primary hyperuricemia, intercritical gouty arthritis, and gouty tophi. By inhibiting renal urate reabsorption, benzbromarone increases urinary uric acid excretion, lowers serum uric acid levels, and helps prevent recurrent gout attacks and urate crystal deposition.

Mechanism: Benzbromarone selectively inhibits the renal URAT1 transporter, reducing uric acid reabsorption and promoting urinary uric acid excretion.
Drug class: Uricosuric agent (URAT1 inhibitor).
Clinical use: Long-term management of primary hyperuricemia and gout in patients with decreased uric acid excretion.

Specification

Generic Name	Benzbromarone Tablets
Brand Name	Narcaricin mite®; ErTongShu®
Ingredient	Benzbromarone
Dosage Form	Tablet
Package	50 mg/tablet, 10 tablets/carton
Conditions Treated	Primary hyperuricemia, gout, gouty tophi
Taboos	Hypersensitivity to benzbromarone, severe hepatic impairment, severe renal impairment, uric acid kidney stones, acute gout attack, pregnancy and breastfeeding
Place of origin	Germany; China
Prescription type	Prescription Drug (Rx)
Storage Conditions	Store below 25°C in a dry place, protected from light.
Manufacturer	Excella GmbH & Co. KG; YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
Registration Authority	National Medical Products Administration (NMPA), China
Approval Number	HJ20171301; H20040348
Approval Date	August 18, 2022; May 20, 2025
Shelf Life	60 months; 36 months

How to use ?

Recommended Dose: The recommended starting dose is 50 mg once daily after breakfast. If serum uric acid remains above target after several weeks, the dose may be increased to 100 mg once daily, followed by the lowest effective maintenance dose.

Time: Take once daily after breakfast at the same time each day. Treatment should be started only after an acute gout attack has completely resolved.

Instructions for use: Swallow the tablet with water and maintain adequate hydration throughout treatment. Drinking 1.5–2 liters of water daily and urine alkalization, when appropriate, may help reduce the risk of kidney stones.

Interaction: High-dose aspirin may reduce the uricosuric effect of benzbromarone. Use caution with hepatotoxic medicines or diuretics, and monitor liver and kidney function during combined therapy.

Side effects: Common adverse reactions include gastrointestinal discomfort, diarrhea, nausea, and elevated liver enzymes. Serious but rare reactions include severe liver injury, allergic reactions, kidney stones, and acute kidney injury.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support